SGCB and pulmonary hypertension: Under specific pathological conditions such as circadian disruption35, NO production is decreased, thus inducing dysfunction of the NO-sGC-cGMP signaling pathway, thereby leading to the development of many cardiovascular diseases, such as heart failure, pulmonary hypertension, atherosclerosis, chronic kidney diseases, and hypertension36–39.